Latest Insider Transactions at Reliance Global Group, Inc. (RELI)
This section provides a real-time view of insider transactions for Reliance Global Group, Inc. (RELI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Reliance Global Group, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Reliance Global Group, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 07
2025
|
Ezra Beyman Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,495
-6.62%
|
$21,495
$1.88 P/Share
|
|
Feb 07
2025
|
Yaakov Beyman Exec VP, Insurance Division |
SELL
Payment of exercise price or tax liability
|
Direct |
7,603
-7.75%
|
$7,603
$1.88 P/Share
|
|
Feb 07
2025
|
Joel Markovits Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,056
-7.83%
|
$17,056
$1.88 P/Share
|
|
Feb 05
2025
|
Ezra Beyman Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
66,000
+16.89%
|
-
|
|
Feb 05
2025
|
Yaakov Beyman Exec VP, Insurance Division |
BUY
Grant, award, or other acquisition
|
Direct |
16,250
+14.21%
|
-
|
|
Feb 05
2025
|
Joel Markovits Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,000
+18.36%
|
-
|
|
Feb 05
2025
|
Ben Fruchtzweig Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,990
+14.71%
|
-
|
|
Feb 05
2025
|
Scott Korman Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,990
+14.68%
|
-
|
|
Feb 05
2025
|
Sheldon Brickman Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,990
+14.71%
|
-
|
|
Feb 05
2025
|
Alex Blumenfrucht Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,140
+7.88%
|
-
|
|
Feb 04
2025
|
Ezra Beyman Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
22,318
-7.94%
|
$22,318
$1.96 P/Share
|
|
Feb 04
2025
|
Yaakov Beyman Exec VP, Insurance Division |
SELL
Payment of exercise price or tax liability
|
Direct |
7,373
-8.27%
|
$7,373
$1.96 P/Share
|
|
Feb 04
2025
|
Joel Markovits Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,537
-8.92%
|
$16,537
$1.96 P/Share
|
|
Jan 21
2025
|
Ezra Beyman Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+47.08%
|
-
|
|
Jan 21
2025
|
Yaakov Beyman Exec VP, Insurance Division |
BUY
Grant, award, or other acquisition
|
Direct |
82,534
+48.06%
|
-
|
|
Jan 21
2025
|
Joel Markovits Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
185,221
+49.98%
|
-
|
|
Jan 21
2025
|
Alex Blumenfrucht Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,109
+49.64%
|
-
|
|
Jan 21
2025
|
Sheldon Brickman Director |
BUY
Grant, award, or other acquisition
|
Direct |
47,505
+47.39%
|
-
|
|
Jan 21
2025
|
Scott Korman Director |
BUY
Grant, award, or other acquisition
|
Direct |
47,505
+47.33%
|
-
|
|
Jan 21
2025
|
Ben Fruchtzweig Director |
BUY
Grant, award, or other acquisition
|
Direct |
47,505
+47.38%
|
-
|
|
Jan 02
2025
|
Joel Markovits Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10
-5.41%
|
$20
$2.89 P/Share
|
|
Dec 23
2024
|
Yaakov Beyman Exec VP, Insurance Division |
SELL
Open market or private sale
|
Direct |
3,001
-31.04%
|
$9,003
$3.8 P/Share
|
|
Dec 23
2024
|
Alex Blumenfrucht Director |
SELL
Open market or private sale
|
Direct |
5,236
-91.54%
|
$15,708
$3.69 P/Share
|
|
Dec 02
2024
|
Joel Markovits Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12
-6.09%
|
$12
$1.54 P/Share
|
|
Nov 22
2024
|
Joel Markovits Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,603
-98.18%
|
$10,603
$1.37 P/Share
|
|
Nov 01
2024
|
Joel Markovits Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10
-0.09%
|
$20
$2.38 P/Share
|
|
Oct 02
2024
|
Joel Markovits Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9
-0.08%
|
$18
$2.36 P/Share
|
|
Sep 04
2024
|
Joel Markovits Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9
-0.08%
|
$18
$2.67 P/Share
|
|
Aug 22
2024
|
Ezra Beyman Chairman and CEO |
SELL
Bona fide gift
|
Indirect |
3,000
-19.39%
|
-
|
|
Aug 01
2024
|
Joel Markovits Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8
-0.07%
|
$24
$3.6 P/Share
|
|
Jul 19
2024
|
Joel Markovits Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8
-0.07%
|
$24
$3.96 P/Share
|
|
Jun 26
2024
|
Ezra Beyman Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
30,000
+5.39%
|
$0
$0.28 P/Share
|
|
Jun 18
2024
|
Joel Markovits Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
27,000
-12.78%
|
$0
$0.7 P/Share
|
|
Jun 18
2024
|
Yaakov Beyman Exec VP, Insurance Division |
SELL
Open market or private sale
|
Direct |
15,000
-25.52%
|
$0
$0.78 P/Share
|
|
Jun 17
2024
|
Ben Fruchtzweig Director |
SELL
Grant, award, or other acquisition
|
Direct |
3,118
-37.26%
|
-
|
|
Jun 17
2024
|
Alex Blumenfrucht Director |
BUY
Grant, award, or other acquisition
|
Direct |
53,000
+35.28%
|
-
|
|
Jun 17
2024
|
Joel Markovits Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
41,869
-16.51%
|
$0
$0.57 P/Share
|
|
Jun 17
2024
|
Joel Markovits Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
185,000
+42.18%
|
-
|
|
Jun 17
2024
|
Yaakov Beyman Exec VP, Insurance Division |
SELL
Payment of exercise price or tax liability
|
Direct |
41,413
-18.76%
|
$0
$0.57 P/Share
|
|
Jun 17
2024
|
Yaakov Beyman Exec VP, Insurance Division |
BUY
Grant, award, or other acquisition
|
Direct |
162,000
+42.32%
|
-
|
|
Jun 17
2024
|
Scott Korman Director |
BUY
Grant, award, or other acquisition
|
Direct |
53,000
+36.76%
|
-
|
|
Jun 17
2024
|
Sheldon Brickman Director |
BUY
Grant, award, or other acquisition
|
Direct |
53,000
+37.32%
|
-
|
|
Jun 17
2024
|
Ezra Beyman Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
55,787
-10.09%
|
$0
$0.57 P/Share
|
|
Jun 17
2024
|
Ezra Beyman Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
249,000
+31.05%
|
-
|
|
Jun 07
2024
|
Joel Markovits Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
149
-0.22%
|
$0
$0.26 P/Share
|
|
May 30
2024
|
Ezra Beyman Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
186,000
+37.97%
|
$0
$0.27 P/Share
|
|
May 21
2024
|
Joel Markovits Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
156
-0.23%
|
$0
$0.26 P/Share
|
|
Apr 11
2024
|
Joel Markovits Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
131
-0.19%
|
$0
$0.35 P/Share
|
|
Mar 06
2024
|
Joel Markovits Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
121
-0.18%
|
$0
$0.48 P/Share
|
|
Feb 02
2024
|
Joel Markovits Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
122
-0.18%
|
$0
$0.46 P/Share
|